BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28567587)

  • 1. Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study.
    Kromer C; Xu J; Ostrom QT; Gittleman H; Kruchko C; Sawaya R; Barnholtz-Sloan JS
    J Neurooncol; 2017 Aug; 134(1):55-64. PubMed ID: 28567587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.
    Ascha MS; Ostrom QT; Wright J; Kumthekar P; Bordeaux JS; Sloan AE; Schumacher FR; Kruchko C; Barnholtz-Sloan JS
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):917-925. PubMed ID: 31053636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
    Goncalves PH; Peterson SL; Vigneau FD; Shore RD; Quarshie WO; Islam K; Schwartz AG; Wozniak AJ; Gadgeel SM
    Cancer; 2016 Jun; 122(12):1921-7. PubMed ID: 27062154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
    Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE
    J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of prognosis of synchronous brain metastases in small-cell lung cancer patients.
    Reddy SP; Dowell JE; Pan E
    Clin Exp Metastasis; 2020 Aug; 37(4):531-539. PubMed ID: 32500410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological trends, prognostic factors, and survival outcomes of synchronous brain metastases from 2015 to 2019: a population-based study.
    Parker M; Jiang K; Rincon-Torroella J; Materi J; Azad TD; Kamson DO; Kleinberg LR; Bettegowda C
    Neurooncol Adv; 2023; 5(1):vdad015. PubMed ID: 36968289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors for incidence risk and prognosis in non-small-cell lung cancer patients with synchronous brain metastasis: a population-based study.
    Zhu H; Zhou L; Guo Y; Yang G; Dong Q; Zhang Z; Chen M; Yang Q
    Future Oncol; 2021 Jul; 17(19):2461-2473. PubMed ID: 33706557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of clinical characteristics on risk and prognosis of synchronous brain metastases in small-cell lung cancer patients: A population-based study.
    Zhou G; Zhang Z; Yu P; Geng R; Wang G; Ma W; Gao J; Zheng Z; Li Y
    Cancer Med; 2023 Jan; 12(2):1195-1203. PubMed ID: 35831985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of brain metastasis at initial presentation of lung cancer.
    Villano JL; Durbin EB; Normandeau C; Thakkar JP; Moirangthem V; Davis FG
    Neuro Oncol; 2015 Jan; 17(1):122-8. PubMed ID: 24891450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal and gender-related trends in brain metastases from lung and breast cancer.
    Yawn BP; Wollan PC; Schroeder C; Gazzuola L; Mehta M
    Minn Med; 2003 Dec; 86(12):32-7. PubMed ID: 14719614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
    Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
    Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience.
    Che W; Liu J; Fu T; Wang X; Lyu J
    Curr Oncol; 2022 Nov; 29(11):8374-8389. PubMed ID: 36354720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.
    Zhang AS; Ostrom QT; Kruchko C; Rogers L; Peereboom DM; Barnholtz-Sloan JS
    Neuro Oncol; 2017 May; 19(5):726-735. PubMed ID: 28039365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.
    Schouten LJ; Rutten J; Huveneers HA; Twijnstra A
    Cancer; 2002 May; 94(10):2698-705. PubMed ID: 12173339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain: the common site of relapse in patients with pancoast or superior sulcus tumors.
    Shah H; Anker CJ; Bogart J; Graziano S; Shah CM
    J Thorac Oncol; 2006 Nov; 1(9):1020-2. PubMed ID: 17409988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
    Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
    JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.